GlassScriptPhysician profile
Steven Paul Hauben
NPI 1730216953
$1,162.74
in general payments reported to CMS, 2019-2025
14 companies · $209 in 2025
The $209 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.19 · 2020: $251 · 2021: $156 · 2022: $159 · 2023: $149 · 2024: $215 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $318.92 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $295.09 | 2019-2025 | Doc Band |
| Pfizer INC. | $239.09 | 2020-2024 | |
| Sanofi Pasteur INC. | $90.63 | 2022-2024 | |
| Ars Pharmaceuticals Operations, INC. | $38.24 | 2025 | Neffy |
| Supernus Pharmaceuticals, INC. | $36.09 | 2021-2022 | |
| Organon LLC | $34.44 | 2021-2023 | Nexplanon |
| Glaxosmithkline, LLC. | $24.21 | 2020 | |
| Kaleo, INC. | $20.07 | 2020 | |
| Sobi, INC | $20.03 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.96 | 2024 | |
| Focal Therapeutics, INC. | $12.15 | 2020 | |
| Tris Pharma INC | $12.12 | 2020 | |
| Corium, LLC | $2.70 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hauben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.